Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2000Antimicrobial Agents and ChemotherapyOpen Access

Mutations in the Beginning of the rpoB Gene Can Induce Resistance to Rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MHM. HeepGlobal Antibiotic Research & Development PartnershipURUlrich M. RiegerAgaplesion Markus HospitalDBDaniela BeckUniversity Hospital Regensburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heep et al. (2000) studied this question.

synapsesocial.com/papers/6a9c7d0d9beff30feb5d305fhttps://doi.org/10.1128/aac.44.4.1075-1077.2000
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro Anti- Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-16571999 · 59 citations
  2. 2Treatment of Antibiotic-ResistantHelicobacter pyloriInfection1998 · 60 citations
  3. 3Contribution of <i>rpoB</i> Mutations to Development of Rifamycin Cross-Resistance in <i>Mycobacterium tuberculosis</i>1998 · 240 citations